543 related articles for article (PubMed ID: 16807406)
1. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
[TBL] [Abstract][Full Text] [Related]
2. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
Matsumoto Y; Ueda S; Yamagishi S; Matsuguma K; Shibata R; Fukami K; Matsuoka H; Imaizumi T; Okuda S
J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
[TBL] [Abstract][Full Text] [Related]
3. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
4. Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD).
Ueda S; Yamagishi S; Matsumoto Y; Kaida Y; Fujimi-Hayashida A; Koike K; Tanaka H; Fukami K; Okuda S
Life Sci; 2009 Jun; 84(23-24):853-6. PubMed ID: 19351540
[TBL] [Abstract][Full Text] [Related]
5. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
Shibata R; Ueda S; Yamagishi S; Kaida Y; Matsumoto Y; Fukami K; Hayashida A; Matsuoka H; Kato S; Kimoto M; Okuda S
Nephrol Dial Transplant; 2009 Apr; 24(4):1162-9. PubMed ID: 19015171
[TBL] [Abstract][Full Text] [Related]
6. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
Chen Y; Xu X; Sheng M; Zhang X; Gu Q; Zheng Z
Exp Eye Res; 2009 Dec; 89(6):1028-34. PubMed ID: 19748504
[TBL] [Abstract][Full Text] [Related]
7. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
[TBL] [Abstract][Full Text] [Related]
8. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
Okubo K; Hayashi K; Wakino S; Matsuda H; Kubota E; Honda M; Tokuyama H; Yamamoto T; Kajiya F; Saruta T
Hypertens Res; 2005 Feb; 28(2):181-9. PubMed ID: 16025746
[TBL] [Abstract][Full Text] [Related]
9. Anti-hypertensive effects of shichimotsukokato in 5/6 nephrectomized Wistar rats mediated by the DDAH-ADMA-NO pathway.
Bai F; Makino T; Ono T; Mizukami H
J Nat Med; 2012 Oct; 66(4):583-90. PubMed ID: 22350214
[TBL] [Abstract][Full Text] [Related]
10. The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.
Minakuchi H; Wakino S; Hosoya K; Sueyasu K; Hasegawa K; Shinozuka K; Yoshifuji A; Futatsugi K; Komatsu M; Kanda T; Tokuyama H; Hayashi K; Itoh H
Nephrol Dial Transplant; 2016 Mar; 31(3):413-23. PubMed ID: 26516203
[TBL] [Abstract][Full Text] [Related]
11. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Desai A; Zhao Y; Warren JS
Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
[TBL] [Abstract][Full Text] [Related]
13. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
Onozato ML; Tojo A; Leiper J; Fujita T; Palm F; Wilcox CS
Diabetes; 2008 Jan; 57(1):172-80. PubMed ID: 17909098
[TBL] [Abstract][Full Text] [Related]
14. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
Anderssohn M; Maass LM; Diemert A; Lüneburg N; Atzler D; Hecher K; Böger RH
Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):152-6. PubMed ID: 22285683
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome.
Kaida Y; Ueda S; Yamagishi S; Nakayama Y; Ando R; Iwatani R; Fukami K; Okuda S
Life Sci; 2012 Sep; 91(9-10):301-5. PubMed ID: 22749861
[TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
[TBL] [Abstract][Full Text] [Related]
17. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
Wang Y; Zhang M; Liu Y; Liu Y; Chen M
Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
[TBL] [Abstract][Full Text] [Related]
18. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
[TBL] [Abstract][Full Text] [Related]
19. Impact of high salt independent of blood pressure on PRMT/ADMA/DDAH pathway in the aorta of Dahl salt-sensitive rats.
Cao Y; Mu JJ; Fang Y; Yuan ZY; Liu FQ
Int J Mol Sci; 2013 Apr; 14(4):8062-72. PubMed ID: 23584024
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
